• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨髓源性循环祖细胞 CD34⁺ 频率与缺血性心肌糖尿病患者病冠状动脉数量之间的关系。

Relation between the frequency of CD34⁺ bone marrow derived circulating progenitor cells and the number of diseased coronary arteries in patients with myocardial ischemia and diabetes.

机构信息

Department of Internal Medicine, Division of Cardiology, University Hospital Rostock, Germany.

出版信息

Cardiovasc Diabetol. 2011 Nov 25;10:107. doi: 10.1186/1475-2840-10-107.

DOI:10.1186/1475-2840-10-107
PMID:22118372
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3235974/
Abstract

BACKGROUND

Bone marrow-derived circulating progenitor cells (BM-CPCs) in patients with coronary heart disease are impaired with respect to number and mobilization. However, it is unknown whether the mobilization of BM-CPCs depends on the number of diseased coronary arteries. Therefore, in our study, we analysed the correlation between the diseased coronary arteries and the frequency of CD34/45+ BM-CPCs in peripheral blood (PB) in patients with ischemic heart disease (IHD).

METHODS

The frequency of CD34/45+ BM-CPCs was measured by flow cytometry in 120 patients with coronary 1 vessel (IHD1, n = 40), coronary 2 vessel (IHD2, n = 40), coronary 3 vessel disease (IHD3, n = 40) and in a control group of healthy subjects (n = 40). There was no significant difference of the total number of cardiovascular risk factors between IHD groups, beside diabetes mellitus (DM), which was significantly higher in IHD3 group compared to IHD2 and IHD1 groups.

RESULTS

The frequency of CD34/45+ BM-CPCs was significantly reduced in patients with IHD compared to the control group (CD34/45+; p < 0.001). The frequency of BM-CPCs was impaired in patients with IHD3 compared to IHD1 (CD34/45+; p < 0.001) and to IHD2 (CD34/45+; p = 0.001). But there was no significant difference in frequency of BM-CPCs between the patients with IHD2 and IHD1 (CD34/45+; p = 0.28). In a subgroup we observed a significant negative correlation between levels of hemoglobin AIc (HbAIc) and the frequency of BM-CPCs (CD34/45+; p < 0.001, r = -0.8).

CONCLUSIONS

The frequency of CD34/45+ BM-CPCs in PB is impaired in patients with IHD. This impairment may augment with an increased number of diseased coronary arteries. Moreover, the frequency of CD34/45+ BM-CPCs in ischemic tissue is further impaired by diabetes in patients with IHD.

摘要

背景

冠心病患者骨髓来源的循环祖细胞(BM-CPCs)在数量和动员方面存在受损。然而,目前尚不清楚 BM-CPCs 的动员是否取决于患病冠状动脉的数量。因此,在本研究中,我们分析了缺血性心脏病(IHD)患者外周血(PB)中 CD34/45+ BM-CPCs 的频率与患病冠状动脉之间的相关性。

方法

通过流式细胞术测量 120 例单支病变(IHD1,n=40)、双支病变(IHD2,n=40)、三支病变(IHD3,n=40)冠心病患者和 40 例健康对照组中 CD34/45+ BM-CPCs 的频率。除糖尿病(DM)外,IHD 组的心血管危险因素总数无显著差异,而 IHD3 组的 DM 明显高于 IHD2 和 IHD1 组。

结果

与对照组相比,IHD 患者的 CD34/45+ BM-CPCs 频率显著降低(CD34/45+;p<0.001)。与 IHD1 相比,IHD3 患者的 BM-CPCs 频率受损(CD34/45+;p<0.001),与 IHD2 相比(CD34/45+;p=0.001)。然而,IHD2 和 IHD1 患者的 BM-CPCs 频率无显著差异(CD34/45+;p=0.28)。在一个亚组中,我们观察到 HbAIc(HbAIc)水平与 BM-CPCs 频率之间存在显著负相关(CD34/45+;p<0.001,r=-0.8)。

结论

IHD 患者 PB 中 CD34/45+ BM-CPCs 的频率受损。这种损伤可能随着患病冠状动脉数量的增加而增加。此外,在 IHD 患者中,缺血组织中 CD34/45+ BM-CPCs 的频率进一步受到糖尿病的损害。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdd9/3235974/c93f27c0983b/1475-2840-10-107-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdd9/3235974/1d6b4c195661/1475-2840-10-107-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdd9/3235974/f92528c3e90e/1475-2840-10-107-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdd9/3235974/e9caf85ec61e/1475-2840-10-107-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdd9/3235974/c93f27c0983b/1475-2840-10-107-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdd9/3235974/1d6b4c195661/1475-2840-10-107-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdd9/3235974/f92528c3e90e/1475-2840-10-107-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdd9/3235974/e9caf85ec61e/1475-2840-10-107-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdd9/3235974/c93f27c0983b/1475-2840-10-107-4.jpg

相似文献

1
Relation between the frequency of CD34⁺ bone marrow derived circulating progenitor cells and the number of diseased coronary arteries in patients with myocardial ischemia and diabetes.骨髓源性循环祖细胞 CD34⁺ 频率与缺血性心肌糖尿病患者病冠状动脉数量之间的关系。
Cardiovasc Diabetol. 2011 Nov 25;10:107. doi: 10.1186/1475-2840-10-107.
2
Correlation between the functional impairment of bone marrow-derived circulating progenitor cells and the extend of coronary artery disease.骨髓源性循环祖细胞功能障碍与冠状动脉疾病程度的相关性。
J Transl Med. 2012 Jul 9;10:143. doi: 10.1186/1479-5876-10-143.
3
Impaired mobilization of CD133(+) bone marrow-derived circulating progenitor cells with an increased number of diseased coronary arteries in ischemic heart disease patients with diabetes.在患有糖尿病的缺血性心脏病患者中,病变冠状动脉数量增加导致 CD133(+)骨髓源性循环祖细胞动员受损。
Circ J. 2011;75(11):2635-41. doi: 10.1253/circj.cj-10-1284. Epub 2011 Aug 9.
4
Improved mobilization of the CD34(+) and CD133(+) bone marrow-derived circulating progenitor cells by freshly isolated intracoronary bone marrow cell transplantation in patients with ischemic heart disease.经皮冠状动脉内自体骨髓单个核细胞移植对缺血性心脏病患者骨髓源循环祖细胞(CD34+和 CD133+)的动员作用增强。
Stem Cells Dev. 2011 Sep;20(9):1491-501. doi: 10.1089/scd.2010.0373. Epub 2010 Dec 29.
5
Factors influencing spontaneous mobilization of CD34+ and CD133+ progenitor cells after myocardial infarction.心肌梗死后影响CD34+和CD133+祖细胞自发动员的因素。
Eur J Clin Invest. 2007 Nov;37(11):842-51. doi: 10.1111/j.1365-2362.2007.01876.x.
6
Circulating progenitor cells and coronary microvascular dysfunction: Results from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation - Coronary Vascular Dysfunction Study (WISE-CVD).循环祖细胞与冠状动脉微血管功能障碍:美国国立心肺血液研究所资助的女性缺血综合征评估 - 冠状动脉血管功能障碍研究(WISE-CVD)的结果
Atherosclerosis. 2016 Oct;253:111-117. doi: 10.1016/j.atherosclerosis.2016.08.026. Epub 2016 Aug 26.
7
Detailed analysis of bone marrow from patients with ischemic heart disease and left ventricular dysfunction: BM CD34, CD11b, and clonogenic capacity as biomarkers for clinical outcomes.缺血性心脏病和左心室功能障碍患者骨髓的详细分析:骨髓CD34、CD11b和克隆形成能力作为临床结局的生物标志物
Circ Res. 2014 Oct 24;115(10):867-74. doi: 10.1161/CIRCRESAHA.115.304353. Epub 2014 Aug 18.
8
Accelerated cellular senescence as underlying mechanism for functionally impaired bone marrow-derived progenitor cells in ischemic heart disease.加速细胞衰老作为缺血性心脏病中骨髓来源祖细胞功能受损的潜在机制。
Atherosclerosis. 2017 May;260:138-146. doi: 10.1016/j.atherosclerosis.2017.03.023. Epub 2017 Mar 19.
9
Progenitor Cells and Clinical Outcomes in Patients With Acute Coronary Syndromes.祖细胞与急性冠状动脉综合征患者的临床结局。
Circ Res. 2018 May 25;122(11):1565-1575. doi: 10.1161/CIRCRESAHA.118.312821. Epub 2018 Mar 7.
10
Enhanced mobilization of the bone marrow-derived circulating progenitor cells by intracoronary freshly isolated bone marrow cells transplantation in patients with acute myocardial infarction.经冠状动脉内移植新鲜分离的骨髓细胞增强急性心肌梗死后骨髓源性循环祖细胞的动员。
J Cell Mol Med. 2012 Apr;16(4):852-64. doi: 10.1111/j.1582-4934.2011.01358.x.

引用本文的文献

1
The Inhibition of Prolyl Endopeptidase (PREP) by KYP-2047 Treatment to Reduce Myocardial Ischemia/Reperfusion Injury.KYP-2047治疗通过抑制脯氨酰内肽酶(PREP)减轻心肌缺血/再灌注损伤
Antioxidants (Basel). 2025 Apr 8;14(4):442. doi: 10.3390/antiox14040442.
2
Behind the monocyte's mystique: uncovering their developmental trajectories and fates.单核细胞的神秘面纱背后:揭示其发育轨迹与命运
Discov Immunol. 2023 Jul 19;2(1):kyad008. doi: 10.1093/discim/kyad008. eCollection 2023.
3
The Long Telling Story of "Endothelial Progenitor Cells": Where Are We at Now?

本文引用的文献

1
Changes of dendritic cells and fractalkine in type 2 diabetic patients with unstable angina pectoris: a preliminary report.2 型糖尿病不稳定型心绞痛患者树突状细胞及 fractalkine 的变化:初步报告
Cardiovasc Diabetol. 2011 Jun 10;10:50. doi: 10.1186/1475-2840-10-50.
2
Insulin resistance impairs circulating angiogenic progenitor cell function and delays endothelial regeneration.胰岛素抵抗会损害循环血管生成祖细胞的功能,从而延缓内皮细胞的再生。
Diabetes. 2011 Apr;60(4):1295-303. doi: 10.2337/db10-1080. Epub 2011 Feb 11.
3
Improvement of cardiac function by intracoronary freshly isolated bone marrow cells transplantation in patients with acute myocardial infarction.
“内皮祖细胞”的漫长故事:我们现在在哪里?
Cells. 2022 Dec 28;12(1):112. doi: 10.3390/cells12010112.
4
Rapid and selective mobilization of specific stem cell types after consumption of a polyphenol-rich extract from sea buckthorn berries () in healthy human subjects.食用沙棘果富含多酚的提取物后,健康人体中特定干细胞类型的快速和选择性动员。
Clin Interv Aging. 2019 Feb 4;14:253-263. doi: 10.2147/CIA.S186893. eCollection 2019.
5
Reduced levels of circulating endothelial progenitor cells in acute myocardial infarction patients with diabetes or pre-diabetes: accompanying the glycemic continuum.糖尿病或糖尿病前期急性心肌梗死患者循环内皮祖细胞水平降低:伴随血糖连续变化。
Cardiovasc Diabetol. 2014 Jun 16;13:101. doi: 10.1186/1475-2840-13-101.
6
The contralateral extremity has also benefit from the locally administered bone marrow-derived mononuclear cells and cord blood serum in diabetic ischemic wound healing.在糖尿病性缺血性创面愈合中,局部给予的骨髓源性单核细胞和脐血血清也使对侧肢体受益。
Stem Cell Rev Rep. 2014 Feb;10(1):97-102. doi: 10.1007/s12015-013-9480-1.
7
Correlation between the functional impairment of bone marrow-derived circulating progenitor cells and the extend of coronary artery disease.骨髓源性循环祖细胞功能障碍与冠状动脉疾病程度的相关性。
J Transl Med. 2012 Jul 9;10:143. doi: 10.1186/1479-5876-10-143.
8
Advanced glycation end products impair the migration, adhesion and secretion potentials of late endothelial progenitor cells.晚期内皮祖细胞的迁移、黏附和分泌潜能受损与糖基化终产物有关。
Cardiovasc Diabetol. 2012 Apr 30;11:46. doi: 10.1186/1475-2840-11-46.
9
Vascular stem cells in diabetic complications: evidence for a role in the pathogenesis and the therapeutic promise.糖尿病并发症中的血管干细胞:在发病机制中的作用证据和治疗潜力。
Cardiovasc Diabetol. 2012 Apr 23;11:37. doi: 10.1186/1475-2840-11-37.
10
The possible role of ribosomal protein S6 kinase 4 in the senescence of endothelial progenitor cells in diabetes mellitus.核糖体蛋白 S6 激酶 4 在糖尿病内皮祖细胞衰老中的可能作用。
Cardiovasc Diabetol. 2012 Feb 2;11:12. doi: 10.1186/1475-2840-11-12.
经冠状动脉内移植新鲜分离的骨髓细胞改善急性心肌梗死患者的心功能。
Circ J. 2011;75(3):683-91. doi: 10.1253/circj.cj-10-0817. Epub 2011 Jan 24.
4
Improved mobilization of the CD34(+) and CD133(+) bone marrow-derived circulating progenitor cells by freshly isolated intracoronary bone marrow cell transplantation in patients with ischemic heart disease.经皮冠状动脉内自体骨髓单个核细胞移植对缺血性心脏病患者骨髓源循环祖细胞(CD34+和 CD133+)的动员作用增强。
Stem Cells Dev. 2011 Sep;20(9):1491-501. doi: 10.1089/scd.2010.0373. Epub 2010 Dec 29.
5
Improved functional activity of bone marrow derived circulating progenitor cells after intra coronary freshly isolated bone marrow cells transplantation in patients with ischemic heart disease.经冠状动脉内新鲜分离骨髓细胞移植治疗缺血性心脏病患者后,骨髓来源循环祖细胞的功能活性得到改善。
Stem Cell Rev Rep. 2011 Sep;7(3):646-56. doi: 10.1007/s12015-010-9220-8.
6
Smoking is associated with depletion of circulating endothelial progenitor cells and elevated pulmonary artery systolic pressure in patients with coronary artery disease.吸烟与冠心病患者循环内皮祖细胞耗竭和肺动脉收缩压升高有关。
Am J Cardiol. 2010 Nov 1;106(9):1248-54. doi: 10.1016/j.amjcard.2010.06.045. Epub 2010 Sep 9.
7
Comparison of patients with heart failure and preserved left ventricular ejection fraction among those with versus without diabetes mellitus.比较伴有和不伴有糖尿病的左心室射血分数保留型心力衰竭患者。
Am J Cardiol. 2010 Feb 1;105(3):373-7. doi: 10.1016/j.amjcard.2009.09.041. Epub 2009 Dec 22.
8
Effects of exercise training on mobilization and functional activity of blood-derived progenitor cells in patients with acute myocardial infarction.运动训练对急性心肌梗死患者血液源性祖细胞动员及功能活性的影响。
Eur J Med Res. 2009 Sep 1;14(9):393-405. doi: 10.1186/2047-783x-14-9-393.
9
Folic acid supplementation normalizes the endothelial progenitor cell transcriptome of patients with type 1 diabetes: a case-control pilot study.补充叶酸可使1型糖尿病患者的内皮祖细胞转录组正常化:一项病例对照试点研究。
Cardiovasc Diabetol. 2009 Aug 25;8:47. doi: 10.1186/1475-2840-8-47.
10
Pioglitazone treatment stimulates circulating CD34-positive cells in type 2 diabetes patients.吡格列酮治疗可刺激2型糖尿病患者循环中的CD34阳性细胞。
Diabetes Res Clin Pract. 2008 Sep;81(3):327-30. doi: 10.1016/j.diabres.2008.05.012. Epub 2008 Jul 17.